MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells
Abstract Background Melanoma is notoriously resistant to all current modalities of cancer therapies including chemotherapy. In recent years, microRNAs (miRNAs) have emerged as molecular regulators in the development and progression of melanoma. However, the relationship between microRNA and chemo-re...
Main Authors: | Yuxia Li, Jie Zhang, Yajing Liu, Bingyue Zhang, Fubo Zhong, Shubin Wang, Zhengyu Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4233-9 |
Similar Items
-
Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis
by: Furong Zeng, et al.
Published: (2023-05-01) -
IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
by: Hima Patel, et al.
Published: (2021-11-01) -
Predominance of triple wild-type and IGF2R mutations in mucosal melanomas
by: Yuuki Iida, et al.
Published: (2018-10-01) -
Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers
by: Hanna Lawnicka, et al.
Published: (2020-03-01) -
MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
by: Julia C. F. Quintanilha, et al.
Published: (2021-05-01)